Maven Securities LTD Sells 77,039 Shares of Guardian Pharmacy Services, Inc. $GRDN

Key Points

• Maven Securities LTD significantly reduced its holdings in Guardian Pharmacy Services, Inc. by 70.2%, owning 32,684 shares after selling 77,039 shares during the first quarter.
• Several investment firms, including JPMorgan Chase & Co. and BNP Paribas Financial Markets, have recently acquired new positions in the company, reflecting growing interest among major investors.
• Analysts have set a price target of $28.00 for Guardian Pharmacy Services, with a consensus rating of "Buy," indicating positive outlook from multiple research firms.

Maven Securities LTD lessened its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 70.2% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 32,684 shares of the company's stock after selling 77,039 shares during the period. Maven Securities LTD owned about 0.05% of Guardian Pharmacy Services worth $695,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of GRDN. BNP Paribas Financial Markets bought a new position in Guardian Pharmacy Services during the 4th quarter valued at approximately $37,000. JPMorgan Chase & Co. bought a new position in Guardian Pharmacy Services during the 4th quarter valued at approximately $77,000. Meeder Asset Management Inc. bought a new position in Guardian Pharmacy Services during the 1st quarter valued at approximately $88,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in Guardian Pharmacy Services during the 4th quarter valued at approximately $98,000. Finally, MetLife Investment Management LLC bought a new position in Guardian Pharmacy Services during the 4th quarter valued at approximately $114,000.

Guardian Pharmacy Services Stock Performance

Shares of Guardian Pharmacy Services stock traded up $0.47 during midday trading on Monday, hitting $26.26. The company had a trading volume of 38,748 shares, compared to its average volume of 165,872. The stock has a market capitalization of $1.66 billion and a P/E ratio of -17.30. The company has a 50 day moving average of $21.28 and a 200 day moving average of $21.59. Guardian Pharmacy Services, Inc. has a 52-week low of $14.16 and a 52-week high of $26.91.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on GRDN shares. Raymond James Financial set a $28.00 price target on Guardian Pharmacy Services and gave the company an "outperform" rating in a research report on Wednesday, May 14th. Wall Street Zen raised Guardian Pharmacy Services from a "hold" rating to a "strong-buy" rating in a research report on Sunday, August 17th. Finally, Truist Financial reaffirmed a "buy" rating and set a $28.00 price target (up previously from $25.00) on shares of Guardian Pharmacy Services in a research report on Monday, May 19th. Three investment analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, Guardian Pharmacy Services presently has a consensus rating of "Buy" and a consensus target price of $25.67.

Insider Buying and Selling

In related news, insider David K. Morris sold 68,547 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $1,381,907.52. Following the sale, the insider owned 214,495 shares in the company, valued at $4,324,219.20. This represents a 24.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Thomas J. Salentine, Jr. sold 651,454 shares of the company's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $20.16, for a total value of $13,133,312.64. Following the completion of the sale, the director owned 1,939,817 shares in the company, valued at $39,106,710.72. The trade was a 25.14% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 11,344,912 shares of company stock worth $228,713,426 over the last three months. Corporate insiders own 63.71% of the company's stock.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.